Lymphatic mapping for the dissection of the sentinel node in the treatment of breast carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 1, 1999, Pages 75-77

  Carcoforo, P ^a   Feggi, L ^b   Sartori, A ^a   Navarra, G ^a   Pozza, E ^a   Donini, I ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Breast carcinoma; Lymphoscintigraphy; Sentinel lymph node

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS;

EID: 0032928884     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Axelsson C.K., Mour-idsen H.T., Zedeler K.: Axillary dissection of Level I and 11 lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur. J. Cancer 28A:1415-1418, 1992.
2. Ball A., Waters R., Fish S., Thomas J.: Radical axillary dissecton in the staging and treatment of breast cancer. Ann. Royal Coll. Surg. 1992; 74:126-129.
3. Boova R., Bonanni R., Rosato F.: Patterns of axillary nodal involvement in breast cancer predictability of level one dissection. Ann. Surg. 1982; 196:642-644.
4. Cabanes P., Salmon R., Vilcoq J., et al.: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992; 339(8804): 1245-1248.
5. Carter C.L., Allen C., henson D.E.: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187, 1989.
6. Chadha M., Chabon A.B., Friedmann P., Vikram B.: Predictors of axillary lymph node metastases in patients with TI breast cancer. A multivariate analysis. Cancer 73:350-353, 1994.
7. Danforth D.N. Jr., Findlay P.A., McDonald H.D., et al.: Complete axillary lymph node dissection for stage 1-11 carcinoma of the breast. J. Clin. Oncol. 4:655-662, 1986.
8. Davies G., Millis R., Hayward J.: Assessment of axillary lymph node status. Ann. Surg. 1980; 192:148-151.
9. Moffat F., Senofsky G., Davis K., et al.: Axillary node dissection for early breast cancer: some is good, but all is better. J. Surg. Oncol. 1992; 51:8-13.
10. Sacre R.: Clinical evaluation of axillar lymph nodes to surgical and pathological findings. Eur. J. Surg. Oncol. 1986, 12: 169-173.
11. Senofsky G., Moffat F., Davis K., et al.: Total axillary lymphadenectomy in the management of breast cancer. Arch. Surg. 1991; 126: 1336-1342.
12. Silverstein M.J., Gierson E.D., Waisman J.R., et al.: Axillary lymph node dissection for Tla breast carcinomas. Is it indicated? Cancer 73: 664-667, 1994.
13. Smith J., Gamez-Araujo J., Gailager H., et al.: Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer 1977; 39:527-532.
14. Lin P.P., Allison D.C., Wainstock J., et al.: Impact of axillary lymph node dissection on the therapy of breast cancer patients. J. Clin. Oncol. 1536-1544, 1993.
15. Veronesi U., Rilke F., Luini A., et al.: Distribution of axillary node metastases by level of invasion. Cancer 59: 682-687, 1987.
16. Veronesi U., Luini A., Galimberti V., et al.: Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur. J. Surg. Oncol. 1990; 16:127-133.
17. Veronesi U., Rilke F., Luini A., et al.: Distribution of axillary node metastases by level of invasion: an analysis of 539 cases. Cancer 1986; 59:682-687.
18. Walls J., Boggis C.R., Wilson M., et al.: Treatment of the axilla in patients with screen-detected breast cancer. Br. J. Surg. 80: 436-438, 1993.
19. Wilking N., Rutqvist L., Carstensen J., et al.: Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncologica 1992; 31:29-35.
20. Winchester D.J., Menck H.R., Fremgen A.M., Winchester D.P.: Selection criteria for axillary dissection in breast cancer. Presented at the 48th Cancer Symposium of the Society for Surgical Oncology, Houston, TX, March 1994.
21. Wong J.H., Kopaid K.H., Morton D.L.: The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch. Surg. 125:1298-1302, 1990.
22. Fisher B., Wolmark N., Bauer M., et al.: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg. Gynecol. Obstet. 1981; 152:765-772.
23. Fisher C., Boyle S., Burke M., Price A.: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br. J. Surg. 1993; 80:457-458
24. Pigott J., Nichols R., Maddox W., Balch C.: Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg. Gynecol. Obstet. 1984; 158:255-259.
25. Silverstein M.J., Waisman J.R., Gierson E.D., et al.: Can axillary lymph node dissection be eliminated for selected patients with invasive breast cancer by using a combination of tumor size and palpability to predict nodal positivity? Proc. Am. Soc. Clin. Oncol. 13:56, 1994.
26. Graversen H.P., Blichert-Toft M., Andersen J.A., et al.: Breast cancer: Risk of axillary recurrence in node-negative patients following partial dissection of the axillary. Eur. J. Surg. Oncol. 14:407-412, 1988.
27. Kjaergaard, Blichert-Toft M., Andersen J., et al.: Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br. J. Surg. 1985; 72:365-367.
28. Kissin M.W., Thompson E.M., Price A.B., et al.: The inadequacy of axillary sampling in breast cancer. Lancet 1: 1210-1212, 1982.
29. Steele R., Forrest A., Gibson T., Chetty U.: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br. J. Surg. 1985; 72:368-369.
30. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220:391-401, 1994.
31. Morton D., Wen D., Cochran A.: Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait". Surg. Oncol. Clin. North Am. 1992; 1:247-259.
32. Morton D., Wen D.-R., Wong J., et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 1992; 127:392-399.
33. Thompson J., McCarthy W., Robinson E., et al.: Sentinel lymph node biopsy in 102 patients with clinical stage I melanoma undergoing elective lymph node dissection. Presented at the 47th Annual Cancer Symposium, Society ofsurgical Oncology; March 17-20, 1994; Houston, Texas.
34. Feggi L., Carcoforo P., Prandini N., Sartori A., Corcione S., Beccati D., Candini G.C., Donini I.: Scintigraphic and radio-surgery identification of sentinel node in early stage breast cancer: a preliminary experience. Eur. J. Nucl. Med. 1998, 25: 1036.
35. Carcoforo P., Feggi L., Sartori A., Dialfi V., Pozza E., Donini I.: Reperage Lymphatique pour l'ablation du ganglion lymphatique sentinelle dans le traitment du carcinome mammaire. Annales de Chirurgie 1998, 52, 7: 684-685.